Exchange: PNK Industry: Drug Manufacturers
0.07% $0.0821
America/New_York / 3 mai 2024 @ 15:55
FUNDAMENTALS | |
---|---|
MarketCap: | 10.13 mill |
EPS: | -0.0100 |
P/E: | -8.21 |
Earnings Date: | May 15, 2024 |
SharesOutstanding: | 123.48 mill |
Avg Daily Volume: | 0.0550 mill |
RATING 2024-05-03 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Buy | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | |
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -8.21 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -8.21 | industry: PE -6.21 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.0010 (-98.80%) $-0.0811 |
Date: 2024-05-04 |
Expected Trading Range (DAY) |
---|
$ 0.0731 - 0.0911 ( +/- 10.97%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-06 | Breen Nicole M | Sell | 30 000 | Common Stock |
2022-04-26 | Breen Nicole M | Sell | 20 000 | Common Stock |
2022-04-18 | Breen Nicole M | Sell | 35 000 | Common Stock |
2022-03-28 | Breen Nicole M | Sell | 20 000 | Common Stock |
2022-03-25 | Breen Nicole M | Sell | 15 000 | Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 100 transactions |
Buy: 7 000 | Sell: 1 297 130 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.0821 (0.07% ) |
Volume | 0.0182 mill |
Avg. Vol. | 0.0550 mill |
% of Avg. Vol | 33.07 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.